Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated with Daptomycin: Is it Time to Change the Breakpoint? Academic Article uri icon

Overview

MeSH Major

  • Anti-Bacterial Agents
  • Bacteremia
  • Daptomycin
  • Enterococcus faecium
  • Gram-Positive Bacterial Infections

abstract

  • Daptomycin MICs of 3-4 µg/mL in the initial E. faecium blood isolate predicted microbiological failure of daptomycin therapy, suggesting that modification in the daptomycin breakpoint for enterococci should be considered.

publication date

  • June 15, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4885651

Digital Object Identifier (DOI)

  • 10.1093/cid/ciw173

PubMed ID

  • 27045126

Additional Document Info

start page

  • 1514

end page

  • 1520

volume

  • 62

number

  • 12